Entry into a leasing agreement between Sykehusapotekene i Midt-Norge HF and Elgesetergate 16 Eiendom AS.

Entry into leasing agreement with Elgesetergate 16 Eiendom AS.

Trondheim

Sykehusapotekene Midt-Norge HF (the Central Norway Pharmaceutical Trust) currently leases premises for Sykehusapoteket [the Hospital Pharmacy] in Trondheim, from both St. Olav’s Hospital Trust and a private landlord. Both of the locations are within the hospital area of St. Olav’s Hospital in Trondheim. The Hospital Pharmacy affiliated with St. Olav’s Hospital needs larger premises. Sykehusapotekene has considered multiple alternatives for placement of the Hospital Pharmacy. The premises that Sykehusapotekene needs are office premises, public areas (shop) and laboratory/production premises.

In order to be classified as a hospital pharmacy within the meaning of the Pharmacy Act, there is a requirement for co-location with a hospital. The hospital pharmacy must be placed in the immediate vicinity of the hospital so that the hospital pharmacy can serve their function as a hospital pharmacy. Transport of medicines (where rapid delivery is required) assumes establishment and connection to the hospital’s pneumatic dispatch system. Other deliveries to and from the hospital are planned through the establishment of a culvert (underground passage) connecting the pharmacy to the hospital’s existing passage system. Costs, ownership and operational responsibility for the culvert (the underground passage) are currently not clarified.

Sykehusapotekene has considered multiple alternatives for placement of the Hospital Pharmacy. The requirement and need for co-location with the haplotypes, as well as the requirements set for the premises, means that only one area is considered to be relevant - the area located in a block between Vangslunds Gate and Elgeseter Gate (Elgesetergate 16, and parts of Elgesetergate 18).

Elgesetergate 16 Eiendom AS has plans to erect a new building on the same property, with a total of approx. 19,000 m2 premises, which will be leased out. There is currently a petrol station at Elgesetergate 16. There is also an underground parking basement in the area. The leasing agreement will require demolition of the petrol station.

In the planned lease agreement, the exclusive area for Sykehusapotekene amounts to approx. 6,066 m2 GFA Including a portion of the common area, the total area amounts to approx. 7,716 m2. GFA

The most cost-driving tenant adjustment is establishing a clean room, where the costs are estimated to amount to up to NOK 47 million. Other tenant adjustments include a requirement for a ventilation system, establishment of backup power, as well as goods lifts In addition to this, there will be establishing of a culvert (the underground passage) and pneumatic dispatch system (where the costs are not clarified).

Annual rent amounts to approx. NOK 18.2 million. There are also joint costs of approx. NOK 3 million and parking fees of approx. NOK 0.4 million (annually). The lease price does not include the cost of clean room establishment, nor the costs of establishing the culvert (the underground passage) and the pneumatic dispatch system. The annual lease cost for this is estimated to be NOK 5 million. The total value of the procurement (point II.1.7) and the contract value (point V.2.4) are calculated based on these figures for four years (48 months - cf. the Public Procurement Regulation § 5-4 (12) letter b). However, it has not been clarified if the cost of establishing the clean room, culvert and pneumatic dispatch system are part of the lease price or not. For the clean room it is possible for the costs to be paid by Sykehusapotekene instead of it being part of the lease price. The the culvert and pneumatic dispatch system, as stated, the costs, ownership and operational responsibility are not clarified.

The lease agreement duration is 15 years with an option to extend, cf. point II.2.11.

It has not been clarified who the other tenant(s) will be.

Option to extend for a total of ten years.

The procurement concerns lease of buildings, cf. the exception in the Public Procurement Regulation § 2-4 letter a).

The choice to enter into a lease agreement with Elgesetergate 16 Eiendom AS is based on these premises being the only premises considered relevant.

Although taking care of the hospital pharmacy's needs necessitates certain tenant adjustments, in Sykehusapotekenes assessment it is not a question of a building and construction contract within the meaning of the procurement regulation.

It is a private development project, where Sykehusapotekene is one of few tenants. The lease adjustments safeguard fulfilment of requirements set by public authorities. The reason these are safeguarded in the contract with the landlord is that Sykehusapotekene needs to deal with one contracting party, who will be responsible for the entire delivery in accordance with the lease agreement. A division will lead to unclear interfaces and responsibilities, and is both inappropriate and expensive.

Sykehusapotekene will lease under half of the building area. The area which is exclusively for Sykehusapotekene amounts to less than a third.

The main purpose of the agreement is therefore considered to be lease of the relevant area, cf. the Public Procurement Regulation§ 6 2 (2).

Sykehusapotekene also considers the exception for ‘services that only a specific supplier can deliver’, cf. the regulation § 13-4 letter b, no. 2 and 3, as applicable.

The voluntary ex-ante transparency notice is made by the Central Norway Regional Health Authority on behalf of the Central Norway Pharmaceutical Trust.

The voluntary ex-ante transparency notice includes an entry into contract without notice of a contest on the following grounds:

• The Public Procurement Regulation is not applicable for this procurement.

We refer to further clarification in point IV.1.1.

At the earliest, the contracting authority will enter into the contract after ten days calculated from the day after the date of the notice.